1. A Novel Homozygous Founder Variant of RTN4IP1 in Two Consanguineous Saudi Families.
- Author
-
Aldosary M, Alsagob M, AlQudairy H, González-Álvarez AC, Arold ST, Dababo MA, Alharbi OA, Almass R, AlBakheet A, AlSarar D, Qari A, Al-Ansari MM, Oláhová M, Al-Shahrani SA, AlSayed M, Colak D, Taylor RW, AlOwain M, and Kaya N
- Subjects
- Antioxidants, Carrier Proteins genetics, Humans, Mitochondrial Proteins genetics, Mutation genetics, NADP genetics, Oxidoreductases genetics, Saudi Arabia, Brain Diseases, Optic Atrophy genetics
- Abstract
The genetic architecture of mitochondrial disease continues to expand and currently exceeds more than 350 disease-causing genes. Bi-allelic variants in RTN4IP1 , also known as Optic Atrophy-10 (OPA10), lead to early-onset recessive optic neuropathy, atrophy, and encephalopathy in the afflicted patients. The gene is known to encode a mitochondrial ubiquinol oxidoreductase that interacts with reticulon 4 and is thought to be a mitochondrial antioxidant NADPH oxidoreductase. Here, we describe two unrelated consanguineous families from the northern region of Saudi Arabia harboring a missense variant ( RTN4IP1 :NM_032730.5; c.475G
- Published
- 2022
- Full Text
- View/download PDF